Primary Immunodeficiency (PID)
ASCIA has significantly expanded its range of information for health professionals and patients on Primary Immunodeficiency (PID) since 2014, including the ASCIA Transplantation and PID (TAPID) Project
ASCIA TAPID Project
The main objective of the TAPID project is to have regular collaborations and discussions between immunologists and transplant physicians in major centres that transplant patients with PIDs in Australasia.
At the ASCIA PID (APID) Consultants Meeting in May 2013 the concept of the TAPID (transplantation and PID) project was initiated. Since then:
- TAPID face to face meetings with immunologists and transplant physicians have been held in February 2014 and May 2017.
- TAPID teleconferences have been held (almost monthly) since mid 2014.
This project is supported by an unrestricted educational grant from CSL Behring.
ASCIA Immunodeficiency (ID) Register
The objectives of this project are to:
- Collect data on all patients with primary immune deficiency diseases in Australia and New Zealand.
- Enhance research, therapies and advocacy for primary and secondary immune deficiencies.
This project is supported by unrestricted educational grants from CSL Behring and Octapharma.
The estimated completion date for this project is late 2017.
Updated July 2017